...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Feb. 06, 2019 FMV ZENE!

I understand what you are saying. Perhaps another question is how do other small corporate Canadian businesses get into registered accounts if not for their financial year ends etc?...How is fair value or fair market value assigned in these cases other than by year end financials?....Both my companies have share valuations which are easily derived at year end.

Share
New Message
Please login to post a reply